Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
Syed Ehsan Shah, Hemostasis Key Account Manager at Werfen, shared on LinkedIn:
”This week in Basel, Switzerland Werfen EEMEA together with AFMS team hosted a one-day session on automation in Hemostasis laboratories for our customers from Saudi Arabia.
It was a great opportunity to share knowledge about Werfen Hemostasis Solutions for big specialized hemostasis centers and explore how Werfen automation-HemoCell can truly transform daily hemostasis lab operations.
In the afternoon, participants had the chance to see the HemoCell automation in action in Basel University.
The laboratory supervisor shared valuable insights, highlighting key advantages such as:
- Less than 30 minutes turnaround time
- Full sample traceability
- Complex reflex rules for factor assays
- Reduced staff workload
A big thanks to all the participants and our team members who joined and contributed to the discussions — it’s always inspiring to see how Werfen innovation in Hemostasis continues to enhance lab efficiency and patient care.
Special thanks to Elias Bouchi, Gianpaolo Pozzato and Ahmed Abbas for your support and dedication.”
Stay updated with Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis